EMAIL THIS PAGE TO A FRIEND

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo.


PMID 20067712

Abstract

To discuss the contribution of psoralen and bergapten metabolites on psoralens toxicity. Computational chemistry prediction of metabolic reactions and toxicophoric groups based on the expert systems Derek and Meteor. a total of 15 metabolites were suggested for both psoralen and bergapten based on phase 1 and 2 biotransformations until the 3rd generation. Five toxicophoric substructures were shared among psoralen, bergapten and their corresponding metabolites; one toxicophoric marker (resorcinol) was only identified in bergapten and its biotransformation products. Although the toxic effects of psoralens are well known and documented, there is little information concerning the role of their metabolites in this process. We believe this work add to the knowledge of which molecular substructures are relevant to the process of metabolism and toxicity induction, thus guiding the search and development of more effective and less toxic drugs to treat vitiligo.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

275727
5-Methoxypsoralen, 99%
C12H8O4
69664
Bergapten, analytical standard
C12H8O4